Use of transdermal fentanyl for cancer pain management
Kaiko, R.F.
American Family Physician 47(4): 729-730
1993
ISSN/ISBN: 0002-838X PMID: 8438673 Document Number: 417173
Document emailed within 1 workday
Related Documents
Yu, S-ying.; Sun, Y.; Wu, Y-long.; Qin, S-kui.; Xie, G-ru.; Liu, S-jun.; Sui, G-jie.; Zhang, H-chun. 2005: Transdermal fentanyl for the management of cancer pain: a survey of 4492 patients Zhonghua Zhong Liu Za Zhi 27(6): 369-372Fujimoto, M.; Sakuyama, T.; Mizutani, Y.; Kuroda, T.; Yanaga, K. 2004: Home palliative care--2 case reports: a long-term cancer pain management with transdermal fentanyl Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31 Suppl. 2: 190-193
Mosser, K.H. 1992: Transdermal fentanyl in cancer pain American Family Physician 45(5): 2289-2294
Breitbart, W.; Chandler, S.; Eagel, B.; Ellison, N.; Enck, R.E.; Lefkowitz, M.; Payne, R. 2000: An alternative algorithm for dosing transdermal fentanyl for cancer-related pain Oncology 14(5): 695-705; Discussion 705: 709-717
Iconomou, G.; Viha, A.; Vagenakis, A.G.; Kalofonos, H.P. 2000: Transdermal fentanyl in cancer patients with moderate-to-severe pain: a prospective examination Anticancer Research 20(6c): 4821-4824
Tani, M.; Fuku, A.; Terashita, S.; Kashiwagi, H.; Yukawa, H.; Yamaue, H. 2008: Early conversion from oral morphine to transdermal fentanyl in patients with cancer pain Hepato-Gastroenterology 55(86-87): 1545-1548
Wong, J.O.; Chiu, G.L.; Tsao, C.J.; Chang, C.L. 1997: Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain Acta Anaesthesiologica Sinica 35(1): 25-32
Yamazaki, M.; Aoki, T.; Tachibana, M.; Akashi, T. 2006: Direct conversion from low-dose morphine to transdermal fentanyl: efficacy for cancer pain and quality of life Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(2): 217-221
Heidemann, A.J.; Seaton, T.L. 2001: Do patients prefer transdermal fentanyl or sustained-release oral morphine for treatment of chronic non-cancer pain? Journal of Family Practice 50(10): 897
Lorvidhaya, V.; Katanyoo, K.; Srisomboon, J.; Suprapaphorn, P.; Cheewakriangkrai, C. 2004: Evaluation of safety and efficacy of transdermal therapeutic system-fentanyl in adult patients with gynecological cancer-related pain Journal of the Medical Association of Thailand 87(3): 319-325
Yoshitake, A.; Yamamoto, T.; Susaki, S.; Abe, E. 2014: Opioid combination of transdermal fentanyl and oral oxycodone for pain in a patient with giant-cell tumor of the sacrum Masui. Japanese Journal of Anesthesiology 63(2): 199-202
Fine, P.G. 1997: Fentanyl in the treatment of cancer pain Seminars in Oncology 24(5 Suppl 16: S16
Côté, D. 1993: Dosage of transdermal fentanyl Clinical Pharmacy 12(10): 718
Burza, M.; Ginobbi, P.; Fusco, G.; Laurenzi, L.; Tirelli, W.; Arcuri, E. 1998: Transdermal route as an alternative to oral administration of opioids in cancer pain La Clinica Terapeutica 149(4): 277-280
Maxwell, T. 1999: Cost is not the only consideration for transdermal fentanyl Oncology Nursing Forum 26(3): 496; Author Reply 497
Sakurai, H. 2015: Transdermal System-Buprenorphine and Fentanyl Masui. Japanese Journal of Anesthesiology 64(11): 1145-1150
Schultheiss, P.J.; Morse, B.C.; Baker, W.H. 1995: Evaluation of a transdermal fentanyl system in the dog Contemporary Topics in Laboratory Animal Science 34(5): 75-81
Oechsler, S.; Zimmer, G.; Pedal, I.; Skopp, G. 2009: Has the transdermal patch gone up in smoke? a fatal fentanyl intoxication Archiv für Kriminologie 224(1-2): 26-35
Keane, K.S. 1988: Administering and monitoring epidural analgesia. Epidural fentanyl for postoperative pain management Oncology Nursing Forum 15(6): 820
Kamizato, K.; Noguchi, N.; Fuchigami, T.; Teruya, K.; Kakinohana, M.; Sugahara, K. 2012: Utility of target controlled infusion technique for deciding the fentanyl infusion rate for post-cholecystectomy pain management in a patient on anticoagulant therapy MASUI. Japanese Journal of Anesthesiology 61(12): 1362-1365